Supplementary Figure 3 from A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors

crossref(2023)

引用 0|浏览14
暂无评分
摘要

Enhanced in-vitro killing of EMMESO-PDL1 tumor targets by PD1CD28 modification.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要